Wednesday, February 2, 2011
Savient Pharmaceuticals Inc., of East Brunswick, N.J., has priced $200 million of convertible senior notes. Underwriters have an option to purchase up to an additional $30 million of notes to cover overallotments.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.